Pimtrea (Desogestrel)

Generic Name

Desogestrel

Brand Names

Pimtrea, Kariva, Reclipsen 28, Apri 28, AVERI, Viorele, Simliya, Cyred, Enskyce, Volnea, Isibloom, Azurette, Velivet, Kalliga, Juleber

FDA approval date: October 22, 1999

Form: Kit

What is Pimtrea (Desogestrel)?

Reclipsen™ is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and the Norplant System depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. In a clinical trial with Reclipsen , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. This represents an overall user-efficacy pregnancy rate of.

Approved To Treat

Amenorrhea

Top Global Experts

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Related Clinical Trials

Resistant Starch Usage in Polycystic Ovary Syndrome: Impact on Cardiometabolic Dysfunction and the Gut Microbiome (CORS-PCOS)

Enrollment Status: Recruiting

Publish Date: February 19, 2026

Intervention Type: Drug, Dietary supplement

Study Phase: Phase 2

Summary: This study will enroll women with PCOS to study the effects of first line therapy, oral contraceptive pills, and then either 12 weeks of resistant starch or 12 weeks of placebo to explore if resistant starch improves cardiometabolic parameters or impacts gut dysbiosis compared to placebo.

PPOS and CFA for Elective Freeze-all Ovarian Stimulation Cycles: a Prospective Cross-over Study

Enrollment Status: Recruiting

Publish Date: December 26, 2025

Intervention Type: Drug

Study Phase: Phase 4

Summary: P-CCROSS is a randomized, prospective monocentric phase 4 study with a crossover study design. The aim of the study is to compare patient satisfaction (by means of questionnaires) and treatment compliance with IVF treatment with CFA (corifollitropin alfa) and PPOS (Progestin-Primed Ovarian Stimulation) versus conventional IVF treatment with a recombinant FSH/GnRH antagonist. The study will also co...

Influence of Genetics Variants on the Pharmacokinetics and Pharmacodynamics of Combined Oral Contraceptive Pill Users

Enrollment Status: Recruiting

Publish Date: August 22, 2025

Intervention Type: Drug

Study Phase: Phase 4

Summary: The goal of this clinical trial is to evaluate how differences in specific parts of our DNA can influence how individual bodies break down the hormones contained within oral contraceptive pills, which could affect how well these birth control pills work to prevent pregnancy. The investigators are also interested in exploring how these differences in our DNA can also explain why patients taking the...

View All Clinical Trials